Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care M De Hert, CU Correll, J Bobes, M Cetkovich-Bakmas, DAN Cohen, I Asai, ... World psychiatry 10 (1), 52, 2011 | 2736 | 2011 |
Large recurrent microdeletions associated with schizophrenia H Stefansson, D Rujescu, S Cichon, OPH Pietiläinen, A Ingason, ... nature 455 (7210), 232-236, 2008 | 2018 | 2008 |
Common variants conferring risk of schizophrenia H Stefansson, RA Ophoff, S Steinberg, OA Andreassen, S Cichon, ... Nature 460 (7256), 744-747, 2009 | 1953 | 2009 |
Identification of loci associated with schizophrenia by genome-wide association and follow-up MC O'donovan, N Craddock, N Norton, H Williams, T Peirce, V Moskvina, ... Nature genetics 40 (9), 1053-1055, 2008 | 1313 | 2008 |
Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders HS Akiskal, ML Bourgeois, J Angst, R Post, HJ Möller, R Hirschfeld Journal of affective disorders 59, S5-S30, 2000 | 1295 | 2000 |
Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European … M De Hert, JM Dekker, D Wood, KG Kahl, RIG Holt, HJ Möller European psychiatry 24 (6), 412-424, 2009 | 1174 | 2009 |
Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level M De Hert, DAN Cohen, J Bobes, M Cetkovich-Bakmas, S Leucht, ... World psychiatry 10 (2), 138, 2011 | 1036 | 2011 |
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine N Müller, MJ Schwarz, S Dehning, A Douhe, A Cerovecki, ... Molecular psychiatry 11 (7), 680-684, 2006 | 1014 | 2006 |
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ... American Journal of Psychiatry 174 (3), 216-229, 2017 | 943 | 2017 |
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders … B Bandelow, J Zohar, E Hollander, S Kasper, HJ Moeller, ... The World Journal of Biological Psychiatry 9 (4), 248-312, 2008 | 754 | 2008 |
The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial1 A Burns, M Rossor, J Hecker, S Gauthier, H Petit, HJ Möller, SL Rogers, ... Dementia and geriatric cognitive disorders 10 (3), 237-244, 1999 | 750 | 1999 |
Hippocampal changes in patients with a first episode of major depression T Frodl, EM Meisenzahl, T Zetzsche, C Born, C Groll, M Jäger, ... American Journal of Psychiatry 159 (7), 1112-1118, 2002 | 726 | 2002 |
Integration of fMRI and simultaneous EEG: towards a comprehensive understanding of localization and time-course of brain activity in target detection C Mulert, L Jäger, R Schmitt, P Bussfeld, O Pogarell, HJ Möller, G Juckel, ... Neuroimage 22 (1), 83-94, 2004 | 700 | 2004 |
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia … A Hasan, P Falkai, T Wobrock, J Lieberman, B Glenthoj, WF Gattaz, ... The World Journal of Biological Psychiatry 13 (5), 318-378, 2012 | 692 | 2012 |
Social functioning in depression: a review RM Hirschfeld, SA Montgomery, MB Keller, S Kasper, AF Schatzberg, ... Journal of Clinical Psychiatry 61 (4), 268-275, 2000 | 689 | 2000 |
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of … A Hasan, P Falkai, T Wobrock, J Lieberman, B Glenthoj, WF Gattaz, ... The world journal of biological psychiatry 14 (1), 2-44, 2013 | 677 | 2013 |
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders, part I: treatment of bipolar depression H Grunze, S Kasper, G Goodwin, C Bowden, D Baldwin, R Licht, E Vieta, ... The World Journal of Biological Psychiatry 3 (3), 115-124, 2002 | 660* | 2002 |
Prefrontal transcranial direct current stimulation changes connectivity of resting-state networks during fMRI D Keeser, T Meindl, J Bor, U Palm, O Pogarell, C Mulert, J Brunelin, ... Journal of Neuroscience 31 (43), 15284-15293, 2011 | 659 | 2011 |
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and … M Bauer, A Pfennig, E Severus, PC Whybrow, J Angst, HJ Möller, ... The world journal of biological psychiatry 14 (5), 334-385, 2013 | 608 | 2013 |
Measurement of phosphorylated tau epitopes in the differential diagnosisof Alzheimer disease: a comparative cerebrospinal fluid study H Hampel, K Buerger, R Zinkowski, SJ Teipel, A Goernitz, N Andreasen, ... Archives of general psychiatry 61 (1), 95-102, 2004 | 589 | 2004 |